Abstract
Without any treatment, the prognosis for pemphigus vulgaris is very bleak, and people usually die within 2–5 years due to the complications of the disease, such as the blistering and erosions that then can lead to dehydration and infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Corwin J, Lee KC. Pemphigus vulgaris. In: Ferri FF, editor. Ferri’s clinical advisor 2017. Philadelphia: Elsevier; 2016. p. 945–6.
Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. Philadelphia: Elsevier Saunders; 2012.
Harman KE, Albert S, Black MM, British Association of Dermatologists. Guidelines for the management of pemphigus vulgaris. Br J Dermatol. 2003;149(5):926–37.
Cholera M, Chainani-Wu N. Management of pemphigus vulgaris. Adv Ther. 2016;33(6):910–58.
Colliou N, Picard D, Caillot F, Calbo S, Le Corre S, Lim A, et al. Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response. Sci Transl Med. 2013;5(175):175ra30.
Bope ET, Kellerman RD. Conn’s current therapy 2016. Philadelphia: Elsevier; 2015.
Pasricha JS, Poonam. Current regimen of pulse therapy for pemphigus: minor modifications, improved results. Indian J Dermatol Venereol Leprol. 2008;74:217–21.
Ahmed AR, Scherger JE, Ferri FF, Stevens SR, Strumpf P, Gyulai RP. First consult clinical key. Pemphigus. Elsevier; 2011.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Mohammad Beigi, P.K. (2018). Overview of Treatment. In: A Clinician's Guide to Pemphigus Vulgaris. Springer, Cham. https://doi.org/10.1007/978-3-319-67759-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-67759-0_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67758-3
Online ISBN: 978-3-319-67759-0
eBook Packages: MedicineMedicine (R0)